23 articles
While shield laws profit Big Abortion, they are often harmful to pro-life states, to women, and deadly to the preborn lives they target.
Read →Requiring women to sign a patient agreement form that discusses abortion pill risks "does not appear to be useful" to the abortion industry's goals.
Read →An estimated 6,000 pharmacies are willing to dispense the deadly abortion pill — and this is likely an underestimation — with more than 8,000 prescribers.
Read →The father of the baby "couldn't get over the abortion part of our marriage" and continues to "carry the ultrasound image of the embryo everywhere he goes."
Read →Though one virtual abortion pill dispensary uses humor to advertise on social media, its lack of accuracy and disregard for safety aren't funny.
Read →ANSIRH researchers rolled out a prototype of what an over-the-counter abortion pill might look like, calling it "a dream that could one day be reality."
Read →The abortion pill is the most common method of abortion in the US, which means that it's important for every American to know the facts about it.
Read →Since 2016, women's deaths associated with the abortion pill have increased, even as adverse event reports, filed by manufacturers, have dropped. But why?
Read →The group's recent statement calls abortion "a core component of practice for MFM docs, and says they should tell parents how expensive sick babies can be.
Read →A lawsuit filed by AL, AR, & LA challenges abortion “shield laws” in NY, CA, and MA, calling them "swords disguised as shields and driven into pro-life states."
Read →A fact sheet tells women after a second-trimester chemical abortion they may see the baby's "head, arms, or legs" and tells them to throw the baby in the trash.
Read →Abortion advocates claim abortion philanthropists are not as interested in directly funding abortion as they were immediately following the Dobbs decision.
Read →Abortion industry workers have long reported feelings of stigma, isolation, moral conflict, and emotional distress related to their work, including dealing with fetal remains and repeat abortions. Studies and reports from various countries, including the U.S.
Read →A wrongful death lawsuit in New Mexico resulted in a $200,000 settlement awarded to the estate of a 26-week aborted baby, recognized as a person under the state's Wrongful Death Act, due to the mother's inability to provide informed consent while under the influence of methamphetamine. The lawsuit also accused the abortion providers of unfair trade practices, including failing to inform the mother of substance abuse treatment programs and improperly handling the baby's remains by placing them in medical waste instead of releasing them for funeral services.
Read →Late-term induction abortions often involve injecting the preborn child with a feticide to cause fatal cardiac arrest before inducing labor to deliver a stillborn baby, a procedure some describe as 'euthanasia. Women who have undergone this process report it as emotionally difficult, with some paying large sums for the procedure and expressing grief over not holding their living baby, while others describe it as a 'humane' or 'gentle' method to end the pregnancy.
Read →is this fraud? Abortion businesses are offering "injection only" abortions of feticide late in pregnancy, and then send women to hospitals for "stillbirths."
Read →The Court of Appeals heard oral arguments in Louisiana's lawsuit challenging abortion-pill regulations. Louisiana presented arguments based on state sovereignty and Medicaid costs, seeking specific relief in the case.
Read →Novielli reviews oral arguments in Louisiana's challenge to federal rules permitting mailed abortion pills. She describes the state's claims of legal and financial harm and criticism of the federal government's focus on standing.
Read →One study shows that abortions are being pushed further despite a "lack of clinical guidelines and limited published research" on late abortions after 24 weeks.
Read →A Senate inquiry investigated abortion-pill manufacturers and the financial information they provided or withheld. The limited disclosure of revenue by these manufacturers complicates efforts to scrutinize the industry's incentives and accountability.
Read →Novielli discusses a Senate report's allegations about abortion-pill manufacturers' oversight of certified prescribers. She links those allegations to company revenue and argues that financial incentives may conflict with enforcement of safety requirements.
Read →Novielli analyzes figures on certified abortion-pill prescribers in relation to the broader physician workforce. She discusses reported reasons for not prescribing, including legal concerns, safety questions, and access to surgical backup.
Read →A report appears to confirm that, despite many examples of prescriber non-compliance with FDA's abortion pill rules, manufacturers haven't decertified any.
Read →